These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30110924)
1. Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases. Burger MC; Wagner M; Franz K; Harter PN; Bähr O; Steinbach JP; Senft C J Clin Med; 2018 Aug; 7(8):. PubMed ID: 30110924 [TBL] [Abstract][Full Text] [Related]
2. Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy. Schneider M; Wispel C; Potthoff AL; Heimann M; Borger V; Schaub C; Herrlinger U; Vatter H; Schuss P; Schäfer N Curr Oncol; 2024 Apr; 31(5):2410-2419. PubMed ID: 38785461 [TBL] [Abstract][Full Text] [Related]
3. Lumboperitoneal Shunt Combined With Ommaya Reservoir Enables Continued Intraventricular Chemotherapy for Leptomeningeal Metastasis With Increased Intracranial Pressure. Woo B; Gwak HS; Kwon JW; Shin SH; Yoo H Brain Tumor Res Treat; 2022 Oct; 10(4):237-243. PubMed ID: 36347638 [TBL] [Abstract][Full Text] [Related]
4. Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies. Kramer K; Smith M; Souweidane MM Pediatr Blood Cancer; 2014 Sep; 61(9):1590-2. PubMed ID: 24777835 [TBL] [Abstract][Full Text] [Related]
5. Ventriculoperitoneal shunting with an on-off valve for patients with leptomeningeal metastases and intracranial hypertension. Huntoon KM; Gasco J; Glitza Oliva IC; Ferguson SD; Majd NK; McCutcheon IE Neurooncol Pract; 2024 Feb; 11(1):56-63. PubMed ID: 38222058 [TBL] [Abstract][Full Text] [Related]
6. Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device. McThenia SS; Pandit-Taskar N; Grkovski M; Donzelli MA; Diagana S; Greenfield JP; Souweidane MM; Kramer K J Neurooncol; 2022 May; 157(3):457-463. PubMed ID: 35403968 [TBL] [Abstract][Full Text] [Related]
7. Use of a stop-flow programmable shunt valve to maximize CNS chemotherapy delivery in a pediatric patient with acute lymphoblastic leukemia. Palejwala SK; Stidd DA; Skoch JM; Gupta P; Lemole GM; Weinand ME Surg Neurol Int; 2014; 5(Suppl 4):S273-7. PubMed ID: 25225619 [TBL] [Abstract][Full Text] [Related]
8. Valved or valveless ventriculoperitoneal shunting in the treatment of post-haemorrhagic hydrocephalus: a population-based consecutive cohort study. Andreasen TH; Holst AV; Lilja A; Andresen M; Bartek J; Eskesen V; Juhler M Acta Neurochir (Wien); 2016 Feb; 158(2):261-70; discussion 270. PubMed ID: 26668079 [TBL] [Abstract][Full Text] [Related]
9. Outcomes following cerebrospinal fluid shunting in high-grade glioma patients. Rinaldo L; Brown D; Lanzino G; Parney IF J Neurosurg; 2018 Oct; 129(4):984-996. PubMed ID: 29271709 [TBL] [Abstract][Full Text] [Related]
10. Surgical management of hydrocephalus secondary to intraventricular hemorrhage in the preterm infant. Christian EA; Melamed EF; Peck E; Krieger MD; McComb JG J Neurosurg Pediatr; 2016 Mar; 17(3):278-84. PubMed ID: 26565942 [TBL] [Abstract][Full Text] [Related]
11. Use of the distal double-slit valve system in children with hydrocephalus. Hahn YS Childs Nerv Syst; 1994 Mar; 10(2):99-103. PubMed ID: 8033170 [TBL] [Abstract][Full Text] [Related]